Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ovarian Neoplasms

Free Subscription Articles published in Eur J Obstet Gynecol Reprod Biol Retrieve available abstracts of 56 articles: HTML format

Single Articles

September 2025
1. CHENG X, Liu P, Zhao Q, Ye L, et al
   Niraparib combined with anlotinib after PARPi resistance in ovarian cancer: A single-center retrospective study from China.
   Eur J Obstet Gynecol Reprod Biol. 2025;314:114707.
   PubMed     Abstract available
   
   
   
2. KHASTGIR G, Siwatch S, Singh T, Jain V, et al
   Beyond the Image: Performance of O-RADS, ADNEX, IOTA Simple Rules & RMI 4 in differentiating benign and malignant adnexal masses - An Indian perspective.
   Eur J Obstet Gynecol Reprod Biol. 2025;313:114585.
   PubMed     Abstract available
   
   
   August 2025
3. ROY M, Pace-Loscos T, Schiappa R, Delotte J, et al
   Therapeutic impact of eras protocol implementation in cytoreductive surgery for ovarian cancer.
   Eur J Obstet Gynecol Reprod Biol. 2025;313:114622.
   PubMed     Abstract available
   
   
   July 2025
4. BORIA F, Chiva L, Fernandez-Gonzalez S, Glickman A, et al
   Comparative analysis of Boria's and Suidan's predictive models for complete cytoreduction in advanced ovarian cancer using (18)F-FDG PET/CT.
   Eur J Obstet Gynecol Reprod Biol. 2025;313:114588.
   PubMed     Abstract available
   
   
   June 2025
5. WANG Y, Wang T, Zhou H, Zhang Y, et al
   Oncological and reproductive outcomes of fertility-sparing surgery in young women with early-stage ovarian clear cell carcinoma: A retrospective cohort study.
   Eur J Obstet Gynecol Reprod Biol. 2025;313:114555.
   PubMed     Abstract available
   
   
   
6. ALEXANDER HR, Jain S, Gidwani K, Ulfenborg B, et al
   Novel glycovariant biomarkers of CA125 and CA15-3 and their diagnostic performance across histotypes of ovarian cancer: A multi-cohort study in Sweden and Finland.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114525.
   PubMed     Abstract available
   
   
   
7. BILLMIRE DF, Turk F, Harris AK, Muraru R, et al
   Surgical staging for ovarian sex cord-stromal tumors: What procedural steps are needed?
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114522.
   PubMed     Abstract available
   
   
   
8. RAY MD, Kapoor R, Banthia P
   The nodal cancer index (NCI): An objective approach for systematic lymph node dissection in ovarian carcinomatosis.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114113.
   PubMed     Abstract available
   
   
   
9. RAY MD, Kapoor R
   Paraneoplastic syndromes in ovarian carcinoma: A study on clinical spectrum, treatment and survival perspectives.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114114.
   PubMed     Abstract available
   
   
   
10. LI J, Lu L, Duan J, Gu P, et al
    Fertility-sparing strategies in borderline and malignant ovarian tumors: a comparative analysis of international guideline recommendations.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114111.
    PubMed     Abstract available
    
    
    May 2025
11. YOONG W, Penny Z, Ho J, Ariyo O, et al
    Outcomes and cost-effectiveness of vNOTES vs conventional laparoscopic ovarian cystectomy for ovarian teratoma (dermoid cysts): A comparison of two minimal access routes of surgery.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114087.
    PubMed     Abstract available
    
    
    April 2025
12. EINIG S, Puls T, Reina H, Schoetzau A, et al
    External validation of the IOTA two-step strategy in the preoperative characterization of ovarian masses.
    Eur J Obstet Gynecol Reprod Biol. 2025;310:113981.
    PubMed     Abstract available
    
    
    
13. YAO Y, Fu Y
    Comment on: "Sentinel lymph node biopsy in early stage ovarian cancer: A prospective observational study".
    Eur J Obstet Gynecol Reprod Biol. 2025 Apr 6:113963.
    PubMed    
    
    
    March 2025
14. SHI G, Wang C, Lu Y, Zhang P, et al
    Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei originating from ovarian teratomas: A single-center case series and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:107-112.
    PubMed     Abstract available
    
    
    
15. DITTO A, Fucina S, Chiarello G, Bogani G, et al
    An effective surgical approach to treat obese patients with gynecological disease using a subcutaneous abdominal wall-retraction device to perform low-pressure laparoscopy: A prospective, single-center study.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:55-60.
    PubMed     Abstract available
    
    
    
16. UCCELLA S, Puppo A, Garzon S, Palladino S, et al
    Secondary cytoreductive surgery for ovarian cancer recurrence and first-line maintenance therapy: A multicenter retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:160-167.
    PubMed     Abstract available
    
    
    
17. HEDA A, Rajaram S, Bahadur A, Gaurav A, et al
    Sentinel lymph node biopsy in early stage ovarian cancer: A prospective observational study.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:121-126.
    PubMed     Abstract available
    
    
    February 2025
18. DICK A, Cohen N, Flamer Y, Shekel E, et al
    Sonographic features of ovarian malignancies in children and young adults - A case control study.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:112-115.
    PubMed     Abstract available
    
    
    January 2025
19. TAYYAB M, Butt ZA, Kamala KP, Fareeda, et al
    Safety of niraparib-based regimens in patients with ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;307:121-127.
    PubMed     Abstract available
    
    
    
20. BARBIER DE REULLE C, Rebotier M, Chopin N, Rossi L, et al
    Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy.
    Eur J Obstet Gynecol Reprod Biol. 2025;307:13-20.
    PubMed     Abstract available
    
    
    
21. LIU Y, Wang D, Jia C, Su N, et al
    Clear cell borderline ovarian tumor: A retrospective study and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:75-80.
    PubMed     Abstract available
    
    
    
22. JARA P, De Pace LA, Pina IB, Carballeira CC, et al
    Recurrence rate and quality of life in women with borderline ovarian tumours, according to surgical approach.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:125-131.
    PubMed     Abstract available
    
    
    
23. NAKAMURA K, Ida N, Hirasawa A, Okamoto K, et al
    CD63 as a potential biomarker for patients with ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:87-93.
    PubMed     Abstract available
    
    
    December 2024
24. WARD A, Dampali R, Wang W, Bertoni Sclavi S, et al
    Risk factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;305:292-297.
    PubMed     Abstract available
    
    
    
25. PIO MAIORANO MF, Loizzi V, Maiorano BA, Cormio G, et al
    Haematological toxicity of PARP inhibitors in advanced ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;305:232-240.
    PubMed     Abstract available
    
    
    October 2024
26. KAPOOR S, Singhal S, Dhamija E, Manchanda S, et al
    Diagnostic performance of ultrasound reporting systems in evaluation of adnexal masses: A prospective observational study.
    Eur J Obstet Gynecol Reprod Biol. 2024;301:186-193.
    PubMed     Abstract available
    
    
    
27. TURATI F, Collatuzzo G, Di Maso M, Negri E, et al
    Fraction of cancers attributable to and prevented by reproductive factors and exogenous hormones use in Italy.
    Eur J Obstet Gynecol Reprod Biol. 2024;301:49-54.
    PubMed     Abstract available
    
    
    September 2024
28. AKSAN A, Boran N, Sinem Duru Coteli A, Ustun Y, et al
    Ultra-radical surgery versus standard-radical surgery for the primary cytoreduction of advanced epithelial ovarian cancer; long-term tertiary center experiences.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:125-133.
    PubMed     Abstract available
    
    
    August 2024
29. AIOB A, Lee KB, Kim SI, Kim NK, et al
    Exploring metastasis and recurrence patterns in low-risk grade 3 endometrial cancer: A multicenter retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2024;301:154-159.
    PubMed     Abstract available
    
    
    July 2024
30. SCALIA P, Levin G, Lau S
    Pembrolizumab for metastatic squamous cell carcinoma arising from mature teratoma of the ovary: A letter to the editor.
    Eur J Obstet Gynecol Reprod Biol. 2024 Jul 31:S0301-2115(24)00421.
    PubMed    
    
    
    June 2024
31. ABU-ZAID A, Baradwan S, Alyafi M, Al Baalharith M, et al
    Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:283-288.
    PubMed     Abstract available
    
    
    
32. MOSS E, Taylor A, Andreou A, Ang C, et al
    British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
    Eur J Obstet Gynecol Reprod Biol. 2024;300:69-123.
    PubMed    
    
    
    
33. PERGIALIOTIS V, Feroussis L, Papadatou K, Vlachos DE, et al
    Diaphragmatic stripping in epithelial ovarian cancer at first diagnosis: Impact on morbidity and survival outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:225-230.
    PubMed     Abstract available
    
    
    May 2024
34. LEBEAU J, Leung J, Bernard L, Zeng X, et al
    Phlegmasia cerulea dolens - A rare presentation of ovarian malignancy.
    Eur J Obstet Gynecol Reprod Biol. 2024 May 25:S0301-2115(24)00259.
    PubMed    
    
    
    
35. MIAO K, Lv Q, Zhang L, Zhao N, et al
    Discriminative diagnosis of ovarian endometriosis cysts and benign mucinous cystadenomas based on the ConvNeXt algorithm.
    Eur J Obstet Gynecol Reprod Biol. 2024;298:135-139.
    PubMed     Abstract available
    
    
    April 2024
36. HU D, Qian J, Yin F, Wei B, et al
    Evaluation of serum CA125, HE4 and CA724 and the risk of ovarian malignancy algorithm score in the diagnosis of high-grade serous ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:170-175.
    PubMed     Abstract available
    
    
    
37. GAO Y, Zang L, Ye Y, Ma F, et al
    Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: A case of overall survival lasting for over 5 years.
    Eur J Obstet Gynecol Reprod Biol. 2024 Apr 6:S0301-2115(24)00168.
    PubMed     Abstract available
    
    
    March 2024
38. NATARAJAN P, Martha Schofield A, Elena Vinturache A, Ruthven S, et al
    A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet(R) device.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:311-315.
    PubMed     Abstract available
    
    
    
39. GUZEL D, Terek C, Besler A, Serin G, et al
    PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:321-326.
    PubMed     Abstract available
    
    
    
40. RODOLAKIS I, Liontos M, Pergialiotis V, Haidopoulos D, et al
    Chemotherapy response score as a predictor of survival in ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:233-238.
    PubMed     Abstract available
    
    
    
41. DABI Y, Rockall A, Razakamanantsoa L, Guerra A, et al
    O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:135-142.
    PubMed     Abstract available
    
    
    
42. MALIK N, Sahu B
    Counselling and management of women with genetic predisposition to gynaecological cancers.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:44-48.
    PubMed     Abstract available
    
    
    February 2024
43. BRAUN C, Grunig H, Peikert J, Strobel K, et al
    Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:13-19.
    PubMed     Abstract available
    
    
    
44. GUO L, Kang X, Su Y, Liu X, et al
    Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:107-113.
    PubMed     Abstract available
    
    
    
45. SHIBAHARA M, Kurita T, Harada H, Tsuda Y, et al
    Therapeutic management of uterine tumours resembling ovarian sex cord tumours including a focus on fertility: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2024;295:1-7.
    PubMed     Abstract available
    
    
    January 2024
46. KATSANEVAKIS E, Addo-Yobo W, Bharathan B, Loona A, et al
    Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:105-110.
    PubMed     Abstract available
    
    
    
47. NIE X, Xu T, Zhang L, Cheng W, et al
    The Gustave Roussy immune score as a novel scoring system for predicting platinum resistance in advanced high-grade serous ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:97-104.
    PubMed     Abstract available
    
    
    
48. PETIOT F, Descargues P, Devouassoux-Shisheboran M, You B, et al
    Retrospective analysis of uterine involvement in low grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:191-197.
    PubMed     Abstract available
    
    
    November 2023
49. LIBERIS A, Kyziridis D, Kalakonas A, Tentes AA, et al
    Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:102-106.
    PubMed     Abstract available
    
    
    
50. LUIS ALCAZAR J, Ramon Perez-Vidal J, Tameish S, Chacon E, et al
    Ultrasound for assessing tumor spread in ovarian cancer. A systematic review of the literature and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:194-200.
    PubMed     Abstract available
    
    
    
51. SHARON A, Aiob A, Kais M, Apel-Sarid L, et al
    Detection and dissection of sentinel nodes in endometrial endometrioid cancer with indocyanine green using PinPoint laparoscopy: Analysis of the learning curve.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:91-96.
    PubMed     Abstract available
    
    
    September 2023
52. LEMS E, Leemans JC, Lok CAR, Bongers MY, et al
    Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practice.
    Eur J Obstet Gynecol Reprod Biol. 2023;291:240-246.
    PubMed     Abstract available
    
    
    July 2023
53. PENG Y, Ur Rehman Aziz A, Wang Y, Li Q, et al
    Ovarian steroid cell tumour, not otherwise specified: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2023 Jul 28:S0301-2115(23)00300.
    PubMed    
    
    
    April 2023
54. TZANIS AA, Antoniou SA, Zacharoulis D, Ntafopoulos K, et al
    The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;285:198-203.
    PubMed     Abstract available
    
    
    March 2023
55. MATSUO K, Rau AR, Machida H, Roman LD, et al
    Intraoperative rupture and chemotherapy use in stage I ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023 Mar 20:S0301-2115(23)00105.
    PubMed    
    
    
    January 2023
56. RALSER DJ, Condic M, Otten LA, Koensgen D, et al
    Evolving treatment landscape of advanced endometrial cancer - A current perspective from a German tertiary referral center for gynecological oncology.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:61-63.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.